This site uses cookies to provide you with a more responsive and personalized service. By using this site you agree to our use of cookies. Please read our cookie notice for more information on the cookies we use and how to delete or block them.

Bookmark Email Print page

    More

    Page   1/81   
  • Pathfinder - Deloitte monthly regulatory update - 01/04/2014
    AIFM. CRD IV / CRR. Central securities depositaries. Credit ratings. EMIR. EuSEF. SEPA. Solvency II. PSF - Authorisation. SRM and Single bank resolution fund.
  • Pathfinder - Deloitte monthly regulatory update - 16/04/2014
    AIFM. CRD IV / CRR. Deposit Guarantee Scheme. European Cooperative Society. EMIR. Insurance - Annual return. Insurance - Complaints-handling. Reinsurance - Annual return...
  • Islamic Finance in Europe – Trends and prospects | Whitepaper
    Looking into the share of the Muslim population in Europe, one can expect an increase over the next decades.
  • Re-engineer your supply chain to save lives | Whitepaper
    Healthcare organisations across the globe are struggling to provide the right drug in the right doses to the right patient across the right route, at the right time.
  • Working differently to provide early diagnosis | Whitepaper
    Early diagnosis of disease is better for patients and makes good economic sense.
  • Healthcare 3.0 - Healthcare for the new normal | Whitepaper
    Economic prosperity, aging population, the growing middle income population and sensitive public policy are key demand drivers of better healthcare and infrastructure.
  • Strategic Optimisation Toolkit | Brochure
    New banking regulatory requirements (CRR/CRD IV, EU mortgage directives, MIFID II, etc.) are considerably changing the rules of the game for the banking industry.
  • 2014 Global life sciences outlook | Whitepaper
    The report outlines the top issues facing global life sciences stakeholders, provides a snapshot of activity in a number of geographic markets, and suggests considerations.
  • Measuring the return from pharmaceutical innovation 2013 | Whitepaper
    This Deloitte report is the fourth in an annual series exploring the pharmaceutical industry’s performance in generating a return from its investment in new product innovation.
  • Trust and Corporate services International conference
    Deloitte Luxembourg is pleased to invite you to its third annual Trust and Corporate Services International Conference. Trust & Corporate Services: a key sector for Luxembourg.
  • Page   1/81   
 

Stay connected:
Get connected
Share your comments
More on Deloitte Luxembourg
Learn about our site

Recently published